Anika Therapeutics
ANIK
ANIK
161 hedge funds and large institutions have $554M invested in Anika Therapeutics in 2018 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 46 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
5% less funds holding
Funds holding: 170 → 161 (-9)
30% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 27
Holders
161
Holding in Top 10
1
Calls
$6.59M
Puts
$1.91M
Top Buyers
| 1 | +$6.59M | |
| 2 | +$5.25M | |
| 3 | +$3.61M | |
| 4 |
BlackRock
New York
|
+$3.31M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.99M |
Top Sellers
| 1 | -$17.6M | |
| 2 | -$9.19M | |
| 3 | -$7.45M | |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$6.14M |
| 5 |
First Manhattan
New York
|
-$3.49M |